Copyright
©The Author(s) 2015.
World J Diabetes. Jul 10, 2015; 6(7): 896-911
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.896
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.896
WHO 1998 (Alberti 1998) | EGIR (Balkau 1999) | NCEP/ATP III 2001 (NCEP 2002) | AACE (2003) (Einhorn 2003) | IDF consensus 2005 (Zimmet 2005) | IDF consensus (10 to < 16 yr) (Zimmet 2007) | |
Definition | IGT, IFG, T2DM or lowered insulin sensitivity | Plasma insulin > 75th percentile | 3 of the following | IGT or IFG plus any of the following based on clinical judgement | See below | |
Plus 2 of the following | Plus 2 of the following | |||||
Europoid waist | W:H > 0.90 M | ≥ 94 M | ≥ 102 M | BMI ≥ 25 kg/m2 | ≥ 94 M | > 90th percentile |
circumference (cm) | W:H > 0.85 F or BMI > 30 kg/m2 | ≥ 80 F | ≥ 88 F | ≥ 80 F or BMI > 30 kg/m2 | Plus 2 of the following | |
Plus 2 of the following | ||||||
Triglyceride [mg/dL (mmol/L)] | > 150 (1.7) | > 150 (1.7) | ≥ 150 (1.7) | > 150 (1.7) | > 150 (1.7) | ≥ 150 (1.7) |
HDL [mg/dL (mmol/L)] | < 35 (0.91) M | < 39 (0.91) | < 40 (1.03) M | < 40 (1.03) M | < 40 (1.03) M | < 40 (1.03) |
< 39 (1.01) F | < 50 (1.29) F | < 50 (1.29) F | < 50 (1.29) F | |||
BP (mmHg) | ≥ 140/90 | ≥ 140/90 or on treatment | ≥ 130/85 | ≥ 130/85 | SBP ≥ 130 or DBP ≥ 85 or on treatment | SBP ≥ 130 and/or DBP ≥ 85 |
Glucose [mg/dL (mmol/L)] | IGT, IFG or T2DM | IGT or IFG (but not diabetes) | ≥ 100 (5.6) (Grundy) or diabetes | IGT or IFG (but not diabetes) | ≥ 100 (5.6) | ≥ 100 (5.6) or known T2DM |
Others | Microalbuminuria ACR > 30 mg/g | Other features of IR1 |
- Citation: Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes 2015; 6(7): 896-911
- URL: https://www.wjgnet.com/1948-9358/full/v6/i7/896.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i7.896